Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahad Quhal

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Urologic Oncology|April 23, 2021
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Immunotherapy|September 11, 2023
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
European Urology Oncology|January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomyEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Nature Reviews. Urology|December 24, 2021
The placebo and nocebo effects in functional urologyHadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
BJU International|April 25, 2024
First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapyTakafumi Yanagisawa, Tatsushi Kawada, Kensuke Bekku, et al.
Urologic Oncology|August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progressionFahad Quhal, David D'Andrea, Francesco Soria, et al.
European Urology Focus|May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial CarcinomaEkaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
World Journal of Urology|October 17, 2020
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinomaBenjamin Pradere, David D'Andrea, Victor M Schuettfort, et al.
The Journal of Urology|June 20, 2023
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Tatsushi Kawada, et al.
European Urology Oncology|November 19, 2023
Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple ThresholdsTatsushi Kawada, Sung Ryul Shim, Fahad Quhal, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Urologic Oncology|April 23, 2021
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Immunotherapy|September 11, 2023
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
European Urology Oncology|January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomyEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Nature Reviews. Urology|December 24, 2021
The placebo and nocebo effects in functional urologyHadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
BJU International|April 25, 2024
First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapyTakafumi Yanagisawa, Tatsushi Kawada, Kensuke Bekku, et al.
Urologic Oncology|August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progressionFahad Quhal, David D'Andrea, Francesco Soria, et al.
European Urology Focus|May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial CarcinomaEkaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
World Journal of Urology|October 17, 2020
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinomaBenjamin Pradere, David D'Andrea, Victor M Schuettfort, et al.
The Journal of Urology|June 20, 2023
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Tatsushi Kawada, et al.
European Urology Oncology|November 19, 2023
Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple ThresholdsTatsushi Kawada, Sung Ryul Shim, Fahad Quhal, et al.
Pageof 14